Piper Sandler downgraded Accolade (ACCD) to Neutral from Overweight with a price target of $7.03, down from $9, after Transcarent agreed to acquire the company for $7.03 per share in cash. A shareholder vote on the sale is scheduled for March 27, the analyst noted.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACCD:
- Accolade and Transcarent announce HSR waiting period expiration for merger
- Accolade’s Merger Agreement with Transcarent Poses Strategic and Financial Risks
- Etsy upgraded, Pinterest downgraded: Wall Street’s top analyst calls
- Accolade downgraded to Hold from Buy at Truist
- Accolade downgraded to Equal Weight from Overweight at Stephens